Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.48 |
| ▸ | RAD52 | P43351 | 2/20 | 0.48 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.45 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61439 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL9691972 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10933953 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10932296 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL6236479 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10937742 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL60618 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10975956 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL16604562 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL61327 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1066 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250338665-A1 | A/M/X CRYSTALLINE MATERIAL, PHOTOVOLTAIC DEVICE, AND PREPARATION METHODS THEREOF | CONTEMPORARY AMPEREX TECHNOLOGY HONG KONG LTD (CN) | 2025-10-30 | — | — | US | claimed |
| US-12414404-B2 | A/M/X crystalline material, photovoltaic device, and preparation methods thereof | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-09-09 | — | — | US | claimed |
| US-20250264646-A1 | PHOTOCHROMIC ELEMENT CONTAINING SURFACTANT AND MANUFACTURING METHOD FOR THE SAME | KOREA UNIVERSITY OF TECHNOLOGY AND EDUCATION INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2025-08-21 | — | — | US | claimed |
| CN-116286435-B | Bacillus amyloliquefaciens, mildew preventive containing same and spore preservative and application thereof | 福建洛东生物技术有限公司 | 2025-04-25 | — | — | CN | claimed |
| EP-3810790-B1 | METHOD FOR DETECTING AND/OR IDENTIFYING AT LEAST ONE TARGET MICROORGANISM PRESENT ON A SURFACE | BIOMERIEUX SA (FR) | 2025-04-02 | — | — | EP | claimed |
| CN-119678934-A | Weeding composition, weeding method and application | 湖南省农业科学院 | 2025-03-25 | — | — | CN | claimed |
| CN-116024833-B | Method for recycling traditional Chinese medicine residue resources and pulp molding packaging product | 大家智合(北京)网络科技股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-12152194-B2 | Low surface tension surfactant system for enhancing flow-back performance | SAUDI ARABIAN OIL COMPANY (SA) | 2024-11-26 | — | — | US | claimed |
| WO-2024182353-A1 | A LOW SURFACE TENSION SURFACTANT SYSTEM FOR ENHANCING FLOW-BACK PERFORMANCE | SAUDI ARABIAN OIL COMPANY (SA) | 2024-09-06 | — | — | WO | claimed |
| US-20240294823-A1 | LOW SURFACE TENSION SURFACTANT SYSTEM FOR ENHANCING FLOW-BACK PERFORMANCE | SAUDI ARABIAN OIL COMPANY (SA) | 2024-09-05 | — | — | US | claimed |
| US-20040191854-A1 | Papanicolau staining process | CYTYC CORPORATION | 2004-09-30 | — | — | US | claimed |
| CN-1125880-C | Method for processing mycobacteria | INTEGRATED RES TECH PLC (US) | 2003-10-29 | — | — | CN | claimed |
| EP-1303311-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | Neurochem, Inc. (CA) | 2003-04-23 | — | — | EP | claimed |
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | NEUROCHEM (INTERNATIONAL) LIMITED (GI) | 2002-08-22 | — | — | US | claimed |
| EP-0878715-B1 | Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers | BAYER AG (US) | 2002-07-31 | — | — | EP | claimed |
| WO-2002007781-A2 | AMYLOID TARGETING IMAGING AGENTS AND USES THEREOF | NEUROCHEM INC. (CA) | 2002-01-31 | — | — | WO | claimed |
| US-5639630-A | MIXING BLOOD SAMPLE WITH AQUEOUS REAGENT CONTAINING NONIONIC SURFACTANT, ANIONIC OR ZWITTERIONIC SURFACTANT, FORMALDEHYDE, SUGAR OR SUGAR ALCOHOL, BUFFER; HEATING TO LYSE RED BLOOD CELLS AND FIX WHITE BLOOD CELLS, STAINING WHITE BLOOD CELLS | BAYER CORPORATION (US) | 1997-06-17 | — | — | US | claimed |
| CN-1150460-A | Method for processing mycobacteria | CORNING CLINICAL LAB INC (US) | 1997-05-21 | — | — | CN | claimed |
| US-4608347-A | MIXING LIPID SOLUTION WITH ZWITTERIONIC SURFACTANT AND WATER IMMISCIBLE SOLVENT-REMOVE TURBIDITY | BIOSOL, LTD. | 1986-08-26 | — | — | US | claimed |
| EP-0141879-A1 | Surfactant compositions and methods for clarifying and partitioning aqueous lipid-containing specimens | Bernstam, Victor A. (US) | 1985-05-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115717-A1 | Amyloid targeting imaging agents and uses thereof | APP, APBA1, BACE1 | HTT 20/4885DNM1 590/4885KMT2A 3512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.